You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 28, 2026

Bulk Pharmaceutical API Sources for KLOR-CON M10


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for KLOR-CON M10

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial 204099_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 409316_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 449989_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 451029_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial P5405_SIGMA ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial P9327_SIAL ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial P9333_SIAL ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for KLOR-CON M10

Last updated: August 5, 2025

Introduction

KLOR-CON M10 is a widely used oral potassium chloride supplement indicated for treating hypokalemia. As with any pharmaceutical product, the procurement of high-quality Active Pharmaceutical Ingredients (APIs) is pivotal to ensure efficacy, safety, and regulatory compliance. Given the increasing demand for cost-effectiveness and reliable supply chains, understanding the landscape of bulk API sources for potassium chloride (the API in KLOR-CON M10) is essential for pharmaceutical manufacturers, distributors, and healthcare providers.

Overview of Klor-Con M10 Composition

KLOR-CON M10 contains 10 mEq of potassium chloride (KCl) per tablet. The active ingredient, potassium chloride, is a well-established salt used predominantly for potassium replenishment. Its synthesis, purification, and quality specifications are regulated internationally, with numerous manufacturers supplying bulk APIs globally.

Global API Manufacturing Landscape for Potassium Chloride

The API market for potassium chloride is characterized by a few leading manufacturers primarily located in major pharmaceutical hubs across Asia, Europe, and North America. These manufacturers operate under Good Manufacturing Practices (GMP) standards, ensuring API quality suitable for pharmaceutical applications.

Major API Suppliers for Potassium Chloride

  1. Hubei Biocause Pharmaceutical Co., Ltd. (China)

    • Recognized for producing pharmaceutical-grade potassium chloride APIs.
    • Compliance with GMP standards and certifications from regulatory agencies such as the GMP certificate from China’s medical products regulatory authority.
    • Known for their competitive pricing and consistent quality.
  2. Jost Chemical Co. (U.S.)

    • A long-standing supplier of pharmaceutical and food-grade potassium chloride.
    • Offers high purity, with specifications meeting USP, EP, and JP standards.
    • Emphasizes rigorous quality control and supply reliability.
  3. Xiamen Keyuan Pharmaceutical Co., Ltd. (China)

    • Specialized in manufacturing pharmaceutical salts, including potassium chloride.
    • Provides APIs with comprehensive documentation, including COA, GMP compliance, and stability data.
    • Focused on global distribution channels.
  4. GFS Chemicals (U.S.)

    • Supplies high-quality potassium chloride API and reagents.
    • Known for purity and customized grades for pharmaceutical use.
  5. Qingdao Bega Biological Co., Ltd. (China)

    • Engaged in producing pharmaceutical-grade salts, including potassium chloride.
    • Possesses certification under ISO and GMP standards.
  6. Prasad Chemical Industries Ltd. (India)

    • Offers pharmaceutical-grade potassium chloride APIs.
    • Competitive pricing with large-scale manufacturing capabilities.
    • Strict adherence to quality standards, including USP and EP.

Regional API Sourcing Insights

Asia-Pacific Region

The Asia-Pacific region dominates global potassium chloride API production due to economies of scale, manufacturing expertise, and cost advantages. Chinese and Indian manufacturers supply a significant proportion of API requirements for global markets, including for KLOR-CON M10. The emphasis on PMDA, CFDA, and MHRA certifications ensures compliance with international standards.

Europe

European suppliers like GFS Chemicals and other regional producers prioritize quality assurance, often servicing markets with stringent regulatory requirements such as the European Union and the U.S. FDA. European APIs tend to command a premium but offer high purity and regulatory assurance.

North America

North American API manufacturers focus on high-quality, GMP-certified products suitable for regulatory submissions to the FDA. They also serve as reliable partners for multinational pharmaceutical companies with global supply chain needs.

Key Criteria for Selecting API Suppliers

  • Regulatory Compliance: GMP certification, USP/EP/JPE standards adherence, and regulatory approval documentation.
  • Purity and Quality: High assay purity (>99%), low impurity profile, and stability data.
  • Supply Chain Reliability: Proven track record of timely delivery, capacity for large-volume orders, and contingency planning.
  • Cost Structure: Competitive pricing balanced with quality assurance.
  • Certifications and Documentation: Certificates of Analysis (COA), Material Safety Data Sheets (MSDS), and batch production records.

Regulatory Considerations

Manufacturers sourcing potassium chloride APIs for KLOR-CON M10 must ensure compliance with regulatory standards dictated by authorities such as the FDA, EMA, and regional health agencies. The API supplier’s ability to provide comprehensive documentation, stability data, and certification directly impacts regulatory approval of the final pharmaceutical product.

Challenges in API Sourcing

  • Supply Chain Disruptions: Geopolitical issues, trade restrictions, or pandemics can affect supply continuity.
  • Quality Variability: Variations in manufacturing processes may influence API quality.
  • Price Volatility: Fluctuations in raw material costs and manufacturing expenses impact API pricing.
  • Regulatory Barriers: Differences in regional standards require thorough vetting of API suppliers.

Future Trends and Considerations

Enhanced regulatory scrutiny is expected to continue, emphasizing comprehensive quality management systems among API producers. Furthermore, the trend toward integrating Asia-based manufacturers into the global supply chain is likely to expand, driven by cost advantages and expanding manufacturing capacity. Some pharmaceutical companies are also exploring vertical integration, sourcing APIs directly from established producers to mitigate supply risks.

Conclusion

The procurement of bulk potassium chloride API for KLOR-CON M10 involves navigating an increasingly complex global landscape. Leading suppliers from China, India, and North America offer high-quality, GMP-compliant APIs suitable for manufacturing this essential hypokalemia treatment. Selecting the right source hinges on regulatory compliance, quality assurance, supply reliability, and cost efficiency. As regulatory landscapes evolve, manufacturers must rigorously vet API suppliers to sustain compliance and ensure patient safety.


Key Takeaways

  • The primary API source for KLOR-CON M10 is potassium chloride, produced by manufacturers mainly in China, India, and North America.
  • High standards of GMP certification, purity, and documentation are critical for API sourcing.
  • Asia-Pacific remains a dominant hub for cost-efficient, large-scale API manufacturing, but European and North American suppliers prioritize compliance and quality.
  • Supply chain resilience and regulatory adherence are key considerations amid global disruptions.
  • Strategic supplier vetting, including certification verification and quality attributes, is essential for securing reliable API supply chains.

FAQs

1. What are the main factors to consider when sourcing potassium chloride API for KLOR-CON M10?
Manufacturers should prioritize regulatory compliance, API purity, supply chain reliability, and cost. Certifications such as GMP, USP, EP, and JP compliance are essential for regulatory approval and safety.

2. Are Chinese API manufacturers compliant with international quality standards?
Many Chinese manufacturers operate under GMP and hold certifications recognized internationally. It’s crucial to verify each supplier’s specific certifications and audit reports before procurement.

3. How does regional sourcing impact regulatory approval of KLOR-CON M10?
Sourcing APIs from GMP-compliant suppliers and ensuring thorough documentation helps manufacturers meet regulatory standards across regions like the FDA and EMA, facilitating faster approval processes.

4. What are the potential risks associated with sourcing APIs from Asia?
Risks include supply disruptions, quality variability, geopolitical issues, and logistical challenges. Due diligence and supplier audits mitigate these risks.

5. How can pharmaceutical companies ensure API quality consistency?
Establish rigorous qualification processes, conduct regular audits, review batch records, and require detailed COAs from suppliers to ensure consistent quality.


References

  1. U.S. Pharmacopeia (USP). (2023). USP–The Pharmacopoeia of the United States. Available at: [USP.org].
  2. European Pharmacopoeia (EP). (2023). European Pharmacopoeia. Available at: [EDQM.eu].
  3. Chinese GMP Certification Authority. (2023). GMP Certification Standards and List of Certified Manufacturers.
  4. Jost Chemical Co. (2023). Product Data Sheet – Potassium Chloride.
  5. Industry reports and market analysis by IQVIA, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.